Hypofractionated radiotherapy plus cetuximab in locally advanced head and neck cancer

Clin Oncol (R Coll Radiol). 2008 Nov;20(9):717. doi: 10.1016/j.clon.2008.07.003. Epub 2008 Aug 30.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / radiotherapy*
  • Cetuximab
  • Combined Modality Therapy
  • Dose Fractionation, Radiation*
  • Head and Neck Neoplasms / drug therapy*
  • Head and Neck Neoplasms / radiotherapy*
  • Humans
  • Multicenter Studies as Topic
  • Radiodermatitis / chemically induced
  • Radiodermatitis / etiology*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Cetuximab